health

Why rare-disease drugs could become India’s next pharma frontier

Why rare-disease drugs could become India’s next pharma frontier

Tablets move along the production line at a pharmaceutical plant in Goa, 2017.

Each rare disease affects very few people. However, there are around 8,000 rare diseases, and they cumulatively affect hundreds of millions of people. In India, 1,004 rare genetic disorders have been reported so far.

It used to be that because the number of patients for a rare-disease drug was very small, so the pharmaceutical industry’s interest in developing such drugs was limited. Therefore they were called orphan drugs.

pharmaceutical / Drugs / prescription drugs / disease

  • india
  • disease
  • drug
  • pharma
  • frontier
  • world
  • challenge
  • pathway

This is an excerpt. Stay informed with VidiaNews.

Related news

Weight-loss drugs used in nearly one in 10 homes in Great Britain, study finds
health

Weight-loss drugs used in nearly one in 10 homes in Great Britain, study finds

About 2.6m adults are taking the drugs, fuelled by the regulator’s approval of the pill versions and a rise in male users At least one person is taking weight-loss drugs in 8.5% of households in Great Britain, according to research, meaning there are more homes with GLP-1 users than those containing vegetarians and pescatarians combined. About 2.6 million adults were using weight-loss medication in August, a rise of about 700,000 people since February, according to a survey by Worldpanel by Numerator.

Read →